Immunogenicity and safety of inactivated enterovirus A71 vaccines in children aged 6-35 months in China: a non-inferiority, randomised controlled trial

• Main Authors: Yan Li (Author), Fan Gao (Author), Yamin Wang (Author), Jing Li (Author), Yuxi Zhang (Author), Huakun Lv (Author), Shenyu Wang (Author), Haitao Yang (Author), Xiaoqiang Liu (Author), Keli Li (Author), Huaqing Wang (Author), Zundong Yin (Author), Zhenglun Liang (Author), Zhijie An (Author), Qunying Mao (Author), Zijian Feng (Author)
• Format: Book
• Published: Elsevier, 2021-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Background: China's three inactivated enterovirus A71 (EV-A71) vaccines are the first and currently world's only EV-A71 vaccines approved by a national regulatory authority and used to prevent EV-A71 associated diseases. The three vaccines vary by vaccine strain, manufacturing cel...